Related Experiment Video

Updated: Apr 26, 2026

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

2.2K

Guidance for peptide vaccines for the treatment of cancer

Yoshiyuki Yamaguchi1, Hiroki Yamaue, Takuji Okusaka

  • 1Department of Clinical Oncology, Kawasaki Medical School, Kurashiki, Japan.

Cancer Science
|July 22, 2014
PubMed

Insights

Recent advancements in tumor immunology have spurred the development of novel cancer vaccines. The Japanese Society for Biological Therapy has published guidance for peptide vaccines, emphasizing their unique immune-mediated mechanism for cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Fundamental understanding of tumor immunology has advanced, creating new avenues for cancer vaccines.
  • Cancer vaccine development is a significant global research area, particularly in Japan.
  • There is a critical need for clinical study guidance to facilitate cancer vaccine drug development.

Framework:

  • Peptide vaccines function indirectly by stimulating the immune system against cancer.
  • This mechanism of action differs fundamentally from direct-acting anticancer drugs.
  • Clinical development strategies for peptide vaccines must account for their unique immunomodulatory properties.

Implementation:

  • The Japanese Society for Biological Therapy has developed and published "Guidance for peptide vaccines for the treatment of cancer."
  • This guidance aims to support the responsible and effective development of cancer peptide vaccines.
  • The publication aligns with the society's mission to advance biological therapies for cancer.

Implications:

  • Standardized guidance is essential for translating promising research into viable cancer treatments.
  • The development of effective cancer peptide vaccines holds significant therapeutic potential.
  • Collaboration and input from regulators, industry, and researchers are welcomed to refine these guidelines.
Keywords:
Cancer vaccinesclinical studyguidancenon-clinical studypeptide vaccines

More Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.1K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

8.4K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
86